India · Delayed Price · Currency is INR Hester Biosciences Statistics
Total Valuation
NSE:HESTERBIO has a market cap or net worth of INR 20.67 billion. The enterprise value is 22.62 billion.
| Market Cap | 20.67B |
| Enterprise Value | 22.62B |
Important Dates
The next estimated earnings date is Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | Jul 14, 2026 |
Share Statistics
| Current Share Class | 8.51M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +2.56% |
| Owned by Insiders (%) | 63.80% |
| Owned by Institutions (%) | 0.25% |
| Float | 2.66M |
Valuation Ratios
The trailing PE ratio is 37.14.
| PE Ratio | 37.14 |
| Forward PE | n/a |
| PS Ratio | 6.18 |
| PB Ratio | 5.62 |
| P/TBV Ratio | 5.90 |
| P/FCF Ratio | 44.62 |
| P/OCF Ratio | 32.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.98, with an EV/FCF ratio of 48.85.
| EV / Earnings | 40.66 |
| EV / Sales | 6.77 |
| EV / EBITDA | 23.98 |
| EV / EBIT | 29.90 |
| EV / FCF | 48.85 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.37 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | 4.21 |
| Interest Coverage | 9.34 |
Financial Efficiency
Return on equity (ROE) is 16.56% and return on invested capital (ROIC) is 9.44%.
| Return on Equity (ROE) | 16.56% |
| Return on Assets (ROA) | 6.51% |
| Return on Invested Capital (ROIC) | 9.44% |
| Return on Capital Employed (ROCE) | 13.19% |
| Weighted Average Cost of Capital (WACC) | 6.59% |
| Revenue Per Employee | 6.92M |
| Profits Per Employee | 1.15M |
| Employee Count | 483 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.23 |
Taxes
In the past 12 months, NSE:HESTERBIO has paid 183.52 million in taxes.
| Income Tax | 183.52M |
| Effective Tax Rate | 24.20% |
Stock Price Statistics
The stock price has increased by +27.08% in the last 52 weeks. The beta is 0.49, so NSE:HESTERBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +27.08% |
| 50-Day Moving Average | 2,068.41 |
| 200-Day Moving Average | 1,697.92 |
| Relative Strength Index (RSI) | 63.06 |
| Average Volume (20 Days) | 55,745 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HESTERBIO had revenue of INR 3.34 billion and earned 556.39 million in profits. Earnings per share was 65.40.
| Revenue | 3.34B |
| Gross Profit | 2.46B |
| Operating Income | 692.99M |
| Pretax Income | 758.36M |
| Net Income | 556.39M |
| EBITDA | 816.73M |
| EBIT | 692.99M |
| Earnings Per Share (EPS) | 65.40 |
Balance Sheet
The company has 65.38 million in cash and 1.95 billion in debt, with a net cash position of -1.88 billion.
| Cash & Cash Equivalents | 65.38M |
| Total Debt | 1.95B |
| Net Cash | -1.88B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.68B |
| Book Value Per Share | 423.46 |
| Working Capital | 560.84M |
Cash Flow
In the last 12 months, operating cash flow was 641.41 million and capital expenditures -178.28 million, giving a free cash flow of 463.13 million.
| Operating Cash Flow | 641.41M |
| Capital Expenditures | -178.28M |
| Depreciation & Amortization | 123.74M |
| Net Borrowing | -361.27M |
| Free Cash Flow | 463.13M |
| FCF Per Share | n/a |
Margins
Gross margin is 73.76%, with operating and profit margins of 20.74% and 16.65%.
| Gross Margin | 73.76% |
| Operating Margin | 20.74% |
| Pretax Margin | 22.70% |
| Profit Margin | 16.65% |
| EBITDA Margin | 24.44% |
| EBIT Margin | 20.74% |
| FCF Margin | 13.86% |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | 57.14% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 10.83% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.46% |
| Earnings Yield | 2.69% |
| FCF Yield | 2.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NSE:HESTERBIO has an Altman Z-Score of 4.45 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.45 |
| Piotroski F-Score | 7 |